Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01994720 · ClinicalTrials.gov registry record · Phase 3
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
A Phase 3 study, sponsored by AstraZeneca.
- Completed
- Registry status
- Phase 3
- Development phase
- 13,307
- Enrollment target
NCT01994720 is a Phase 3 study that has completed, run by AstraZeneca. The registered enrollment target is 13,307 participants.
The verdict
NCT01994720, a Phase 3 study, has completed, sponsored by AstraZeneca.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 13,307 participants
- Enrollment target
Study Summary
The primary objective of the study is to compare the effect of 90-day treatment with ticagrelor (180 mg \[two 90 mg tablets\] loading dose on Day 1 followed by 90 mg twice daily maintenance dose for the remainder of the study) vs acetylsalicylic acid (ASA)-aspirin (300 mg \[three 100 mg tablets\] loading dose on Day 1 followed by 100 mg once daily maintenance dose for the remainder of the study) for the prevention of major vascular events (composite of stroke, myocardial infarction \[MI\], and death) in patients with acute ischaemic stroke or transient ischaemic attack (TIA).
Interventions
- DRUG ticagrelor
- DRUG Acetylsalicylic acid (ASA)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13,307 participants |
| Start Date | 2014-01-07 |
| Est. Completion | 2016-03-02 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01994720
The ClinicalTrials.gov registry entry for NCT01994720 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 13,307 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AstraZeneca, which has 1,285 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which ticagrelor is the first listed.
NCT01994720 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01994720 about?
NCT01994720 is a clinical study titled "[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]". The primary objective of the study is to compare the effect of 90-day treatment with ticagrelor (180 mg \[two 90 mg tablets\] loading dose on Day 1 followed by 90 mg twice daily maintenance dose for the remainder of the study) vs acetylsalicylic acid (ASA)-aspirin (300 mg \[three 100 mg tablets\] lo...
What is the current status of trial NCT01994720?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 13,307 participants. The study started on 2014-01-07. Estimated completion is 2016-03-02.
What interventions are being tested in trial NCT01994720?
The interventions under investigation include: ticagrelor (DRUG), Acetylsalicylic acid (ASA) (DRUG).
Who is sponsoring clinical trial NCT01994720?
This trial is sponsored by AstraZeneca, which has 1,285 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.